Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, announced today that Brian M. Culley, Chief Executive Officer, will be presenting at the H.C. Wainwright 21st Annual Global Investment Conference on September 9th, 2019 at 11:15am Eastern Time at the Lotte New York Palace Hotel in the Louis Salon in New York, NY.
September 5, 2019
· 2 min read